MYD88 and B-cell chronic lymphocytic leukemia: Previous studies on the prognostic impact of MYD88 mutations in CLL also have been discordant, as some studies showed a favorable outcome23 whereas others showed an unfavorable prognosis27, and yet others showed no prognostic significance24,28.